32例耐药结核性脑膜炎的疗效及预后分析

发布时间：2018-06-28 21:22

  本文选题：结核性脑膜炎 + 耐药　； 参考：《华西医学》2016年02期

【摘要】：目的分析耐药结核性脑膜炎(TBM)的疗效及预后。方法对2010年1月-2015年12月住院的32例成人耐药TBM患者病历资料进行回顾性分析并电话随访了解患者的预后情况,采用改良Rankin量表(m RS)对预后进行评分。结果 32例耐药TBM患者中好转31例(96.9%),治疗无效死亡1例(3.1%)。治疗后1例出现激素相关性青光眼及骨质疏松,1例出现药物性库欣综合征。27例(84.4%)患者m RS评分≤2分。结论耐药TBM早期诊断困难,经积极抗结核并辅助治疗,疗效满意。
[Abstract]:Objective to analyze the curative effect and prognosis of drug resistant tuberculous meningitis (TBM). Methods the medical records of 32 adult TBM patients who were hospitalized from January 2010 to December 2015 were retrospectively analyzed and their prognosis was evaluated by modified Rankin scale (Mrs). Results among 32 patients with TBM, 31 cases (96.9%) were improved and 1 case (3.1%) died of ineffective treatment. After treatment, one patient developed hormone associated glaucoma and one patient with osteoporosis developed drug-induced Cushing syndrome. 27 patients (84.4%) had MRS 鈮，

本文编号：2079388